Take the Accelerated Path Upstream with IND Compliant CHOK1-GenS Cell Line Development

Speaker: Dr. Ying Li, Director of Downstream Process Development, GenScript ProBio
Date: Jun.28^th, 2022
Time:14:00-15:00 SGT

Biography

Dr. Ying Li is the Director of Process Development for GenScript ProBio (GenScript’s CDMO business). She leads the CMC process development services for protein and antibody, and provides technical leadership in new technology platform development. She joined the company in 2022, bringing over 10 years of biotechnology experience spanning multiple specialties, including bioseparation, bioproduction, viral clearance and MSAT. Prior to joining GenScript ProBio, Dr. Li was an R&D Manager in MilliporeSigma (USA), leading the development of the company’s Gene Therapy manufacturing platform. Dr. Li obtained her B.S (1st Class Honor) in Chemical Engineering from National University of Singapore in 2012 and Ph.D in Chemical Engineering from the Pennsylvania State University in 2017. She is dedicated to innovation in bioprocessing field and a frequent speaker at international conferences including ACS and AIChE.

Background and Abstract

Cell line development plays an essential role in drug development. It is the bridge connecting drug discovery and development, more over a good cell line development service can always save your valuable time and lower your final cost. GenScript ProBio’s ProCLD cell line development service will provide you the desired cell lines with accelerated timeline, high quality delivery and regulatory support to help save your valuable time and lower production cost. With years of experiences, our average titer of cell line development can easily reach 4.35 g/L. Our full cell line development capabilities and expertise span from DNA and vector constructs to top clonal selection, research and master cell banks generation, stability studies and cell culture process optimization. We have a wealth of experience across a wide range of biomolecules at scale, including monoclonal antibody, bispecific antibody, or recombinant protein. We are proudly to help the clients with 18 IND clearances success of our cell line development service.

In this webinar, you will learn: